For instance, the treatment of Leber congenital amaurosis with the RPE-specific 65KDa gene (RPE65) carried by the AAV vector has demonstrated significant improvements in visual function (Maguire et al., 2008; Le Meur et al., 2018). This evidence concerns the gene RPE65 and Leber congenital amaurosis.